Details
- Status
- Closed
- Opening date
- Deadline
- Department
- Directorate-General for Health and Food Safety
Target audience
Public health community
Why we are consulting
Period of consultation
From 19 September 2012 to 28 November 2012.
Contributions to and results of the consultation
A summary of the responses is available here.
Below are the public responses to the above-mentioned public consultation:
- aPODD Foundation
- AEFI - Spanish Association of Pharmacists in Industry
- AMQuidPharma sprll
- BASG - Austrian Medicines and Medical Devices Agency
- Viktoria Behse
- British Generic Manufacturers Association
- CBG-MEB – Dutch Medicines Agency
- CMDh-EMA - Co-ordination Group for Mutual Recognition and Decentralised Procedures - Human
- Dutch Medicines for Children Research, Network (MCRN) and Dutch National Centre of Excellence on Pediatric Pharmacotherapy (NKFK) and the board of the Dutch pediatric Formulary.
- EFPIA - European Federation of Pharmaceutical Industries and Associations
- EGA - European Generic Medicines Association
- EMA-PDCO
- EMAS - PerRe Spain to the EU : Health and Consumer Affairs
- Enpr-EMA - European network of paediatric research
- University Hospital Erlangen, Department of Paediatric and Adolescents Medicine
- ESDP - European Society for Developmental, Perinatal and Paediatric Pharmacology
- EuropaBIO
- EURORDIS - European Organisation for Rare Diseases
- FINPEDMED - Finnish Investigators Network for Pediatric Medicines
- France - Autorités françaises
- University Hospital Ghent, Belgium
- GRIP - Global Research in Paediatrics – Network of Excellence
- ITCC - Innovative Therapies for Children with Cancer
- MCRN - NIHR Medicines for Children Research Network
- MHRA - Medicines and Healthcare products Regulatory Agency (UK)
- NPPG - UK Neonatal and Paediatric Pharmacists Group
- Joop C. van Oene, PhD
- PPTA Europe
- Prescrire
- SEFC - Paediatrics Clinical Pharmacology from Spanish Society of Clinical Pharmacology
- SIOP EUROPE - European Society for Paediatric Oncology
- Christophers Smile (UK)
- Swedish Medical Products Agency
- Thereakind Ltd
- ULG - Faculty of Medecine University of Liège
- UNAPECLE - National Union of childhood cancer parents organisation
- University of Nottingham, Academic Division of Child Health
- UZA Belgium
- Vertex Pharmaceuticals (Switzerland) Sàrl
- ViroPharma SPRL
- Jenny Walsh Consulting Ltd
- Private Universität Witten/Herdecke gGmbH - Fakultät für Medizin
- United parent/patients associations (including Imagine for Margo, ICCCPO, Kids v Cancer, IBTA, Cancer52, Enfants et Santé, L'etoile de Martin, Tous avec Clément)
The consultation document
The consultation document can be downloaded here.
Protection of personal data
The policy on "protection of individuals with regard to the processing of personal data by the Community institutions" is based on Regulation (EC) N° 45/2001 of the European Parliament and of the Council of 18 December 2000. More information is available here.
Additional information:
Respond to the consultation
The response period for this consultation has ended. Thank you for your input.